Alteogen and Biogen Partner for The Development of Subcutaneous Biologics with Hybrozyme™ Technology Alteogen Inc. has partnered with Biogen to license its cutting-edge Hybrozyme™ technology for developing two subcutaneous biologics. This collaboration is set to revolutionize patient care, providing innovative therapies.

Alteogen and Biogen Partner for The Development of Subcutaneous Biologics with Hybrozyme™ Technology #South_Korea #Biogen #Daejeon #Alteogen #Hybrozyme